FDA Investigator Sneha Patel
Sneha Patel has inspections in 1 countries as of 18 Aug 2023. Sneha Patel has collaborated with a combined 711 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
18 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alison N Stieg,
Anastasia I Onuorah,
Atul J Agrawal,
Brooke K Higgins,
Brooke K Seeman,
CDR Ileana Barreto Pettit,
Chaltu N Wakijra,
Dennis L Doupnik,
Diane T Bargo,
Diane T O'brien,
Douglas A Campbell,
Emest F Bizjak,
Guerlain Ulysse,
James M Mason,
Janet A Rajan,
John P Mistler,
Johnna L Bleem,
Jonathan W Chapman,
Katelyn Astaub Zamperini,
Ko U Min,
Kshitij A Patkar,
Lawrence J Stringer,
Marcus A Ray,
Massoud Motamed,
Melissa J Garcia,
Melissa T Roy,
Michelle Marsh,
Nancy M Espinal,
Paula J Bretz,
Pratik S Upadhyay, DDC,
Qin Xu,
Rabin N Ghoshal,
Rebecca E Dombrowski,
Sean R Marcsisin,
Sneha S Patel,
Tamika White,
Tamil Arasu, PhD,
Thomas J Arista,
Toyin B Oladimeji,
William A Warnick,
William L Bargo
Sneha Patel's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2017 | FDA 483 | Mylan Pharmaceuticals Inc. - Form 483, 2017-08-25 |
February, 2020 | FDA 483 | Hetero Drugs Limited - Form 483, 2020-02-14 |
February, 2020 | EIR | Hetero Drugs Limited - EIR, 2020-02-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more